KAWASHIRI Masaaki

J-GLOBAL         Last updated: Oct 14, 2018 at 11:51
 
Avatar
Name
KAWASHIRI Masaaki
Affiliation
Kanazawa University
Section
Hospital, Hospital, Cardiovascular Medicine

Research Interests

 
 

Research Areas

 
 

Academic & Professional Experience

 
2002
 - 
2003
: Kanazawa University 
 
2003
   
 
-: Kanazawa University Hospital 
 
1998
 - 
2000
: University of Pennsylvania, School of Medicine 
 
1994
 - 
1995
: Kanazawa University Hospital 
 

Education

 
 
   
 
Internal medicine II, Graduate School, Division of Medicine, Kanazawa University
 
 
 - 
1994
Faculty of Medicine, Niigata University
 

Committee Memberships

 
2004
   
 
Japan Atherosclerosis Society  
 
2004
   
 
-: Japan Atherosclerosis Society 
 

Published Papers

 
Kawashiri MA, Tada H, Nomura A, Yamagishi M
Journal of cardiology   72(4) 307-313   Oct 2018   [Refereed]
Tada H, Nohara A, Inazu A, Sakuma N, Mabuchi H, Kawashiri MA
Journal of atherosclerosis and thrombosis   25(9) 783-789   Sep 2018   [Refereed]
Tada H, Kawashiri MA, Nomura A, Teramoto R, Hosomichi K, Nohara A, Inazu A, Mabuchi H, Tajima A, Yamagishi M
Journal of clinical lipidology      Aug 2018   [Refereed]
Tada H, Kawashiri MA, Nomura A, Yoshimura K, Itoh H, Komuro I, Yamagishi M
European journal of preventive cardiology   2047487318796989   Aug 2018   [Refereed]
Tada H, Kawashiri MA
Journal of atherosclerosis and thrombosis      Aug 2018   [Refereed]

Misc

 
Lp(a)の新展開 重症家族性高コレステロール血症の治療選択におけるLp(a)の意義
川尻 剛照
日本動脈硬化学会総会プログラム・抄録集   50回 222-222   Jun 2018
私の処方 家族性高コレステロール血症ヘテロ接合体に対する私の処方
川尻 剛照
Modern Physician   38(4) 405-405   Apr 2018
【プレシジョンメディシンの現状と未来】 脂質代謝特論 高LDL-Cのプレシジョンメディシン
多田 隼人, 川尻 剛照, 山岸 正和
The Lipid   29(2) 146-152   Apr 2018
高コレステロール血症および網膜症を有する糖尿病患者において血清中トリグリセリドは初回心血管イベントを予測する 無作為化対照試験の事後解析(Serum Triglyceride Predicts First Cardiovascular Events in Diabetic Patients with Hypercholesterolemia and Retinopathy: Post-hoc Analysis of a Randomized Controlled Trial)
多田 隼人, 野村 章洋, 川尻 剛照, 山岸 正和, 小室 一成, 伊藤 裕
日本循環器学会学術集会抄録集   82回 LBCT1-3   Mar 2018
重度高トリグリセリド血症における臨床的全エクソームシーケンシング(Clinical Whole Exome Sequencing in Severe Hypertriglyceridemia)
多田 隼人, 野村 章洋, 川尻 剛照, 野原 淳, 山岸 正和
日本循環器学会学術集会抄録集   82回 OJ11-8   Mar 2018

Conference Activities & Talks

 
Impact of evolocumab, a PCSK9 inhibitor, withdrawing from regular LDL-apheresis therapy in patients with heterozygous familial hypercholesterolemia
KAWASHIRI Masaaki
European Society of Cardiology 2017   Aug 2017   
Impact of evolocumab, a PCSK9 inhibitor, withdrawing from regular LDL-apheresis therapy in patients with heterozygous familial hypercholesterolemia.
KAWASHIRI Masaaki
Mar 2017   
Who has extreme high cardiovascular risk in patients with familial hypercholesterolemia?
KAWASHIRI Masaaki
10th Asian-Pacific Society of Atherosclerosis & Vascular Diseases   Jul 2016   
Impact of combined lipid lowering with calcium channel antagonist-based blood pressure control on coronary plaque regression: MILLION Study.
KAWASHIRI Masaaki
The Society for Cardiovascular Angiography and Intervention Foundation   May 2015   
Vascular complication in Japanese FH patients.
KAWASHIRI Masaaki
The Satellite Symposium of the 17th International Symposium on Atherosclerosis   May 2015   

Research Grants & Projects

 
Molecular Genetic Research of Atherosclerogenesis
Project Year: 2002